LAUSANNE, Switzerland & LONDON--(BUSINESS WIRE)--ADC Therapeutics Sarl (the Company or ADCT), the oncology research and development company focused on Antibody Drug Conjugates (ADCs) targeting major cancers, today announced the appointment of Dr. Chris Martin...

Dr. Ramsay Richmond is Executive Manager at the QMB Innovation Centre in Whitechapel. He has spent over 25 years in the European life sciences industry covering research, consultancy and business development. This article gives the views of the author and is not...

Date: 4 February Location: Queen Mary Innovation Centre, 42 New Road, London E1 2AX There are two major needs that appear to be driving the global life sciences sector. First there is the global need for innovative and effective new treatments, as evidenced by the...

Does the UK’s Science & Innovation Strategy go far enough? Dr. Ramsay Richmond is Executive Manager at the QMB Innovation Centre in Whitechapel. He has spent over 25 years in the European life sciences industry covering research, consultancy and business...

Co-hosting with One Nucleus In recent years we have run the BioNewRound Award on the eve of Genesis and the finalists present with real time to a small judging panel. This year, we have brought the BioNewsRound Award mainstream with some changes. Entrants will be...

Let’s be More Innovative with our Infrastructure Dr. Ramsay Richmond has spent over 25 years in the European life sciences industry covering research, consultancy and business development. He is Executive Manager at the QMB Innovation Centre in Whitechapel. This...

‘Maker places’ including incubators and science parks are becoming, if not the backbone of our economy, then almost certainly the tibia and fibula, connecting business and innovation to UK Plc. There are an estimated 300 business incubators in the UK supporting in...

We've joined up with Total Bipharma for an informal industry networking night. Please join us for drinks and canapés and feel free to invite your colleagues too.   When: Tuesday 7th October From 6pm-9pm Where: QBM Innovation Centre, please use Walden Street...

Retroscreen Virology Group plc (AIM: RVG), the pioneer of hVIVO Human Challenge Models ("HCMs") of disease, announces today that it has raised, subject to certain conditions, £33.6 million (before expenses) by way of a placing of 12,923,077 new Ordinary Shares (the...

(And why Pfizer will be back) AstraZeneca hasn’t seen the last of Pfizer which will likely return with another bid in November, after a six month cooling off period. While talks could resume as early as August, at AstraZeneca’s invitation, that’s...